New Interferon Formulations Promise to Eliminate Injections in Multiple Sclerosis Treatment
12 janv. 2009 03h01 HE
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - January 12, 2009) - Nerveda Inc. and Aegis Therapeutics LLC today
announced preclinical results from their joint collaboration aimed at
developing non-injectable...
Preclinical Study Presented at the International Congress of Endocrinology Shows Intravail(R) Drug Delivery Technology Provides Unmatched Non-Invasive Delivery of an Anti-Obesity Peptide
12 nov. 2008 15h20 HE
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - November 12, 2008) - Aegis Therapeutics LLC announced today that
preclinical data was presented at the 2008 International Congress of
Endocrinology in Rio de Janeiro,...
Aegis Therapeutics Awarded Patent for Its ProTek(R) Room Temperature Stable Human Growth Hormone Formulations Suitable for Metered Nasal Spray Delivery
16 sept. 2008 04h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - September 16, 2008) - Aegis Therapeutics LLC announced today that
it has been awarded U.S. Patent 7,425,542, titled "Stabilizing
alkylglycoside compositions and methods...
Aegis Therapeutics to Present at the "4th Modern Drug Discovery & Development Summit" in San Diego, CA, October 15-17, 2008
08 sept. 2008 04h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - September 8, 2008) - Aegis Therapeutics, a drug delivery
technology licensing company and leader in transmucosal drug delivery, will
present a talk entitled:...
Aegis Therapeutics to Present at the "13th Annual Drug Delivery Summit" in New Brunswick, NJ, September 22-23, 2008
21 août 2008 04h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, CA--(Marketwire - August 21, 2008) - Aegis Therapeutics, a drug delivery
technology licensing company and leader in transmucosal drug delivery, will
present a talk entitled: "New...
Aegis Therapeutics to Present at the "C21 BioVentures Conference" in Monterey California in May 2007
04 avr. 2007 10h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, CA -- (MARKET WIRE) -- April 4, 2007 -- Aegis Therapeutics, a drug delivery
technology licensing company and leader in transmucosal drug delivery, will
present its recently formed Cedar...
Aegis Therapeutics to Present Intravail(R) and ProTek(R) Technologies at the "Drug Delivery 2007 Conference" in San Francisco on April 10, 2007
03 avr. 2007 17h57 HE
|
Aegis Therapeutics LLC
SAN DIEGO, CA -- (MARKET WIRE) -- April 3, 2007 -- Aegis Therapeutics, a leader in intranasal
drug delivery, will present a talk entitled: "High-Efficiency Delivery of
Peptides, Proteins, and Other...
Aegis Therapeutics to Present at the "2nd Modern Drug Discovery & Development Summit" in Philadelphia in December 2006
16 nov. 2006 09h00 HE
|
Aegis Therapeutics
SAN DIEGO, CA -- (MARKET WIRE) -- November 16, 2006 -- Aegis Therapeutics, a leader in intranasal
drug delivery, will present a talk entitled: "High-Efficiency Transmucosal
Delivery of Peptide and...
Aegis' Intravail(R) Technology Provides Effective Oral Delivery of Anti-Sense Drugs in Primates
15 nov. 2006 16h13 HE
|
Aegis Therapeutics
SAN DIEGO, CA -- (MARKET WIRE) -- November 15, 2006 -- Aegis Therapeutics, a drug delivery
technology company providing exceptionally high and unmatched
bioavailability for non-invasive intranasal...